Medistim ASA (MEDI) — Working Capital to Net Assets Ratio
Medistim ASA (MEDI) has a Working Capital to Net Assets ratio of 68.9% as of June 2025. Working capital of Nkr264.33 Million (current assets of Nkr388.07 Million minus current liabilities of Nkr123.75 Million) is measured against net assets of Nkr383.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See MEDI days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medistim ASA Working Capital to Net Assets (2004–2024)
This chart shows how Medistim ASA's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2004 to 2024. As of June 2025, the ratio stands at 68.9%, reflecting working capital of Nkr264.33 Million against net assets of Nkr383.81 Million NOK. For the complete balance sheet picture, see how large is Medistim ASA's balance sheet.
Annual Working Capital to Net Assets for Medistim ASA (2004–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medistim ASA from 2004 to 2024, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Medistim ASA's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 73.7% | Nkr321.76 Million | Nkr436.61 Million | Nkr429.13 Million | Nkr107.37 Million | ▼ -1.0 pp |
| 2023 | 74.7% | Nkr297.28 Million | Nkr397.94 Million | Nkr391.57 Million | Nkr94.28 Million | ▼ -3.1 pp |
| 2022 | 77.8% | Nkr286.07 Million | Nkr367.69 Million | Nkr385.89 Million | Nkr99.82 Million | ▲ +3.0 pp |
| 2021 | 74.8% | Nkr228.89 Million | Nkr306.05 Million | Nkr306.50 Million | Nkr77.60 Million | ▲ +2.3 pp |
| 2020 | 72.5% | Nkr186.31 Million | Nkr256.85 Million | Nkr245.79 Million | Nkr59.48 Million | ▲ +6.2 pp |
| 2019 | 66.3% | Nkr157.05 Million | Nkr236.86 Million | Nkr228.50 Million | Nkr71.45 Million | ▲ +1.0 pp |
| 2018 | 65.3% | Nkr135.07 Million | Nkr206.71 Million | Nkr190.45 Million | Nkr55.38 Million | ▼ -1.7 pp |
| 2017 | 67.0% | Nkr122.65 Million | Nkr182.98 Million | Nkr180.23 Million | Nkr57.58 Million | ▲ +7.5 pp |
| 2016 | 59.5% | Nkr99.15 Million | Nkr166.70 Million | Nkr146.95 Million | Nkr47.79 Million | ▼ -0.6 pp |
| 2015 | 60.1% | Nkr93.89 Million | Nkr156.16 Million | Nkr149.16 Million | Nkr55.27 Million | ▼ 0.0 pp |
| 2014 | 60.2% | Nkr83.68 Million | Nkr139.10 Million | Nkr134.96 Million | Nkr51.27 Million | ▲ +6.0 pp |
| 2013 | 54.2% | Nkr65.93 Million | Nkr121.64 Million | Nkr104.93 Million | Nkr39.00 Million | ▼ -2.6 pp |
| 2012 | 56.8% | Nkr65.41 Million | Nkr115.17 Million | Nkr98.64 Million | Nkr33.23 Million | ▼ -3.8 pp |
| 2011 | 60.6% | Nkr64.77 Million | Nkr106.89 Million | Nkr94.02 Million | Nkr29.25 Million | ▼ -5.6 pp |
| 2010 | 66.2% | Nkr71.35 Million | Nkr107.83 Million | Nkr97.13 Million | Nkr25.78 Million | ▲ +2.0 pp |
| 2009 | 64.1% | Nkr68.18 Million | Nkr106.29 Million | Nkr92.98 Million | Nkr24.80 Million | ▲ +11.4 pp |
| 2008 | 52.7% | Nkr50.34 Million | Nkr95.46 Million | Nkr85.18 Million | Nkr34.84 Million | ▲ +1.9 pp |
| 2007 | 50.8% | Nkr47.67 Million | Nkr93.83 Million | Nkr66.27 Million | Nkr18.59 Million | ▼ -8.6 pp |
| 2006 | 59.4% | Nkr43.99 Million | Nkr74.06 Million | Nkr69.76 Million | Nkr25.76 Million | ▲ +0.4 pp |
| 2005 | 59.0% | Nkr39.77 Million | Nkr67.41 Million | Nkr54.78 Million | Nkr15.01 Million | ▼ -19.2 pp |
| 2004 | 78.2% | Nkr48.28 Million | Nkr61.71 Million | Nkr59.22 Million | Nkr10.94 Million | — |